2024 News Releases

In five cancer types, prevention and screening have been major contributors to saving lives

• December 5, 2024

Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers

• November 11, 2024

NIH-funded scientists uncover clues to precancer and tumor biology

• October 30, 2024

NIH clinical trial will test precision medicine treatments for myeloid cancers

• October 23, 2024

New cancer diagnoses did not rebound as expected following pandemic

• September 24, 2024

Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer

• September 16, 2024

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

• September 16, 2024

Immunotherapy approach shows potential in some people with metastatic solid tumors

• July 11, 2024

For healthy adults, taking multivitamins daily is not associated with a lower risk of death

• June 26, 2024

Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma

• June 19, 2024

Inherited genetic factors may predict the pattern of X chromosome loss in older women

• June 12, 2024

NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy

• June 3, 2024

Analysis identifies 50 new genomic regions associated with kidney cancer risk

• April 26, 2024

NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients

• April 18, 2024

For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life

• March 7, 2024

Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges

• March 6, 2024

NIH to address dwindling clinical trial patient enrollment with centralized staffing support

• February 29, 2024

NIH launches research network to evaluate emerging cancer screening technologies

• February 21, 2024